Long-Term Partial Remission of AutoImmune Thrombocytopenia in a Patient Treated with the Anti-Tumor Necrosis Factor-Alpha Antibody Infliximab for Refractory Fistulizing Crohn’s Disease

Publisher： Karger

E-ISSN： 1421-9867|78|4|195-200

ISSN： 0012-2823

Source： Digestion, Vol.78, Iss.4, 2008-12, pp. : 195-200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Tumor Necrosis Factor Nonresponders in Crohn’s Disease: Therapeutic Strategies

By  

Digestive Diseases, Vol. 27, Iss. 3, 2009-09 ,pp. : 351-357

Karger

Access to resources Recommend Favorite

Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor α-neutralizing antibody

By Mori Shunsuke   Imamura Fumiya   Kiyofuji Chikage   Sugimoto Mineharu  

Modern Rheumatology, Vol. 16, Iss. 4, 2006-08 ,pp. : 251-255

Springer Publishing Company

Access to resources Recommend Favorite

Tumor Necrosis Factor-Alpha in Ileal Mast Cells in Patients with Crohn’s Disease

By  

Digestion, Vol. 61, Iss. 1, 2000-02 ,pp. : 68-76

Karger

Access to resources Recommend Favorite

Suspected de novo Hepatitis B in a Patient Receiving Anti-Tumor Necrosis Factor Alpha Therapy for the Treatment of Crohn's Disease

By  

Case Reports in Gastroenterology, Vol. 8, Iss. 1, 2014-01 ,pp. : 44-50

Karger

Access to resources Recommend Favorite

Mucormycosis in a Crohn’s Disease Patient Treated with Infliximab

By  

Digestion, Vol. 80, Iss. 3, 2009-09 ,pp. : 182-184

Karger

Access to resources Recommend Favorite